Annual EBIT
-$105.96 M
-$25.94 M-32.41%
December 31, 2023
Summary
- As of February 7, 2025, SAVA annual earnings before interest & taxes is -$105.96 million, with the most recent change of -$25.94 million (-32.41%) on December 31, 2023.
- During the last 3 years, SAVA annual EBIT has fallen by -$99.17 million (-1460.03%).
- SAVA annual EBIT is now -437.82% below its all-time high of $31.36 million, reached on December 31, 2013.
Performance
SAVA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$30.62 M
+$30.78 M+50.13%
September 30, 2024
Summary
- As of February 7, 2025, SAVA quarterly earnings before interest & taxes is -$30.62 million, with the most recent change of +$30.78 million (+50.13%) on September 30, 2024.
- Over the past year, SAVA quarterly EBIT has dropped by -$2.74 million (-9.84%).
- SAVA quarterly EBIT is now -193.07% below its all-time high of $32.90 million, reached on December 31, 2013.
Performance
SAVA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$134.75 M
-$2.74 M-2.08%
September 30, 2024
Summary
- As of February 7, 2025, SAVA TTM earnings before interest & taxes is -$134.75 million, with the most recent change of -$2.74 million (-2.08%) on September 30, 2024.
- Over the past year, SAVA TTM EBIT has dropped by -$30.64 million (-29.43%).
- SAVA TTM EBIT is now -529.61% below its all-time high of $31.36 million, reached on December 31, 2013.
Performance
SAVA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SAVA EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -32.4% | -9.8% | -29.4% |
3 y3 years | -1460.0% | -9.8% | -29.4% |
5 y5 years | -1490.5% | -9.8% | -29.4% |
SAVA EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -222.4% | at low | -112.0% | +50.1% | -310.0% | at low |
5 y | 5-year | -2036.7% | at low | -2216.4% | +50.1% | -2689.8% | at low |
alltime | all time | -437.8% | at low | -193.1% | +50.1% | -529.6% | at low |
Cassava Sciences EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$30.62 M(-50.1%) | -$134.75 M(+2.1%) |
Jun 2024 | - | -$61.40 M(+208.0%) | -$132.00 M(+32.8%) |
Mar 2024 | - | -$19.93 M(-12.5%) | -$99.38 M(-6.2%) |
Dec 2023 | -$105.96 M(+32.4%) | -$22.79 M(-18.3%) | -$105.96 M(+1.8%) |
Sep 2023 | - | -$27.88 M(-3.1%) | -$104.11 M(+6.7%) |
Jun 2023 | - | -$28.78 M(+8.5%) | -$97.57 M(+10.0%) |
Mar 2023 | - | -$26.51 M(+26.6%) | -$88.71 M(+10.9%) |
Dec 2022 | -$80.02 M(+143.5%) | -$20.94 M(-1.9%) | -$80.02 M(+8.8%) |
Sep 2022 | - | -$21.34 M(+7.2%) | -$73.53 M(+18.7%) |
Jun 2022 | - | -$19.92 M(+11.8%) | -$61.94 M(+31.3%) |
Mar 2022 | - | -$17.82 M(+23.4%) | -$47.16 M(+43.5%) |
Dec 2021 | -$32.87 M(+383.9%) | -$14.44 M(+48.1%) | -$32.87 M(+56.2%) |
Sep 2021 | - | -$9.75 M(+89.8%) | -$21.05 M(+65.3%) |
Jun 2021 | - | -$5.14 M(+45.4%) | -$12.73 M(+41.4%) |
Mar 2021 | - | -$3.53 M(+34.6%) | -$9.00 M(+32.6%) |
Dec 2020 | -$6.79 M(+37.0%) | -$2.62 M(+82.6%) | -$6.79 M(+18.2%) |
Sep 2020 | - | -$1.44 M(+2.0%) | -$5.74 M(+12.9%) |
Jun 2020 | - | -$1.41 M(+6.6%) | -$5.09 M(+5.3%) |
Mar 2020 | - | -$1.32 M(-16.1%) | -$4.83 M(-2.6%) |
Dec 2019 | -$4.96 M(-25.6%) | -$1.58 M(+102.3%) | -$4.96 M(+20.0%) |
Sep 2019 | - | -$779.00 K(-32.4%) | -$4.13 M(-10.9%) |
Jun 2019 | - | -$1.15 M(-20.5%) | -$4.64 M(-22.0%) |
Mar 2019 | - | -$1.45 M(+93.5%) | -$5.95 M(-10.7%) |
Dec 2018 | -$6.66 M(-44.2%) | -$750.00 K(-41.6%) | -$6.66 M(-20.1%) |
Sep 2018 | - | -$1.28 M(-47.8%) | -$8.34 M(-13.6%) |
Jun 2018 | - | -$2.46 M(+13.6%) | -$9.65 M(-15.0%) |
Mar 2018 | - | -$2.17 M(-10.6%) | -$11.35 M(-5.0%) |
Dec 2017 | -$11.95 M(-20.1%) | -$2.42 M(-6.7%) | -$11.95 M(-1.0%) |
Sep 2017 | - | -$2.60 M(-37.7%) | -$12.07 M(-7.3%) |
Jun 2017 | - | -$4.17 M(+50.7%) | -$13.01 M(+9.4%) |
Mar 2017 | - | -$2.76 M(+8.7%) | -$11.89 M(-20.5%) |
Dec 2016 | -$14.96 M(+5.3%) | -$2.54 M(-28.2%) | -$14.96 M(-11.7%) |
Sep 2016 | - | -$3.54 M(+16.3%) | -$16.95 M(-0.8%) |
Jun 2016 | - | -$3.04 M(-47.8%) | -$17.09 M(-2.0%) |
Mar 2016 | - | -$5.83 M(+28.6%) | -$17.44 M(+22.8%) |
Dec 2015 | -$14.20 M(+14.2%) | -$4.53 M(+23.0%) | -$14.20 M(+20.0%) |
Sep 2015 | - | -$3.69 M(+8.8%) | -$11.84 M(+1.2%) |
Jun 2015 | - | -$3.39 M(+30.5%) | -$11.69 M(+1.1%) |
Mar 2015 | - | -$2.60 M(+19.8%) | -$11.56 M(-7.0%) |
Dec 2014 | -$12.43 M(-139.6%) | -$2.17 M(-38.9%) | -$12.43 M(-154.9%) |
Sep 2014 | - | -$3.54 M(+8.8%) | $22.64 M(-10.9%) |
Jun 2014 | - | -$3.26 M(-6.0%) | $25.41 M(-10.4%) |
Mar 2014 | - | -$3.46 M(-110.5%) | $28.34 M(-9.6%) |
Dec 2013 | $31.36 M(-904.8%) | $32.90 M(-4340.1%) | $31.36 M(-1028.5%) |
Sep 2013 | - | -$776.00 K(+143.3%) | -$3.38 M(-20.6%) |
Jun 2013 | - | -$319.00 K(-28.0%) | -$4.26 M(+1.6%) |
Mar 2013 | - | -$443.00 K(-75.9%) | -$4.19 M(+7.6%) |
Dec 2012 | -$3.90 M | -$1.84 M(+11.2%) | -$3.90 M(+47.6%) |
Sep 2012 | - | -$1.66 M(+554.2%) | -$2.64 M(+31.5%) |
Jun 2012 | - | -$253.00 K(+70.9%) | -$2.01 M(-36.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | - | -$148.00 K(-74.7%) | -$3.18 M(-9.4%) |
Dec 2011 | -$3.51 M(-74.4%) | -$584.00 K(-42.9%) | -$3.51 M(-71.8%) |
Sep 2011 | - | -$1.02 M(-28.4%) | -$12.44 M(-4.2%) |
Jun 2011 | - | -$1.43 M(+198.1%) | -$12.99 M(+1.3%) |
Mar 2011 | - | -$479.00 K(-95.0%) | -$12.82 M(-6.5%) |
Dec 2010 | -$13.70 M(+102.9%) | -$9.51 M(+505.0%) | -$13.70 M(+133.9%) |
Sep 2010 | - | -$1.57 M(+25.3%) | -$5.86 M(-10.9%) |
Jun 2010 | - | -$1.25 M(-8.0%) | -$6.57 M(+17.7%) |
Mar 2010 | - | -$1.36 M(-18.1%) | -$5.59 M(-17.3%) |
Dec 2009 | -$6.75 M(-177.5%) | -$1.67 M(-27.2%) | -$6.75 M(-15.2%) |
Sep 2009 | - | -$2.29 M(+753.7%) | -$7.96 M(-197.8%) |
Jun 2009 | - | -$268.00 K(-89.4%) | $8.14 M(+39.3%) |
Mar 2009 | - | -$2.53 M(-11.9%) | $5.84 M(-32.9%) |
Dec 2008 | $8.71 M(-14.3%) | -$2.87 M(-120.8%) | $8.71 M(-12.4%) |
Sep 2008 | - | $13.81 M(-638.8%) | $9.95 M(-398.4%) |
Jun 2008 | - | -$2.56 M(-863.1%) | -$3.33 M(-2337.6%) |
Mar 2008 | - | $336.00 K(-120.5%) | $149.00 K(-98.5%) |
Dec 2007 | $10.17 M(-1938.9%) | -$1.64 M(-408.3%) | $10.17 M(+251.9%) |
Sep 2007 | - | $531.00 K(-42.2%) | $2.89 M(-66.8%) |
Jun 2007 | - | $919.00 K(-91.1%) | $8.71 M(-6.3%) |
Mar 2007 | - | $10.36 M(-216.2%) | $9.30 M(-1785.1%) |
Dec 2006 | -$553.00 K(-98.3%) | -$8.92 M(-240.3%) | -$552.00 K(-111.7%) |
Sep 2006 | - | $6.35 M(+321.0%) | $4.71 M(-143.3%) |
Jun 2006 | - | $1.51 M(+200.6%) | -$10.89 M(-52.8%) |
Mar 2006 | - | $502.00 K(-113.7%) | -$23.06 M(-29.5%) |
Dec 2005 | -$32.72 M(-16.0%) | -$3.65 M(-60.5%) | -$32.72 M(-15.9%) |
Sep 2005 | - | -$9.25 M(-13.2%) | -$38.90 M(-0.4%) |
Jun 2005 | - | -$10.66 M(+16.3%) | -$39.06 M(+3.6%) |
Mar 2005 | - | -$9.16 M(-6.8%) | -$37.69 M(-3.3%) |
Dec 2004 | -$38.96 M(+75.1%) | -$9.83 M(+4.5%) | -$38.96 M(+8.0%) |
Sep 2004 | - | -$9.41 M(+1.3%) | -$36.06 M(+10.1%) |
Jun 2004 | - | -$9.29 M(-11.0%) | -$32.75 M(+17.3%) |
Mar 2004 | - | -$10.43 M(+50.5%) | -$27.93 M(+25.5%) |
Dec 2003 | -$22.25 M(-231.5%) | -$6.93 M(+13.8%) | -$22.25 M(-268.7%) |
Sep 2003 | - | -$6.09 M(+36.4%) | $13.19 M(-17.5%) |
Jun 2003 | - | -$4.47 M(-6.1%) | $16.00 M(-34.6%) |
Mar 2003 | - | -$4.76 M(-116.7%) | $24.44 M(-1.8%) |
Dec 2002 | $16.92 M(-197.7%) | $28.51 M(-966.8%) | $24.88 M(-355.8%) |
Sep 2002 | - | -$3.29 M(-182.6%) | -$9.73 M(-6.9%) |
Jun 2002 | - | $3.98 M(-192.1%) | -$10.45 M(-43.1%) |
Mar 2002 | - | -$4.32 M(-29.1%) | -$18.35 M(+6.0%) |
Dec 2001 | -$17.32 M(-14.7%) | -$6.10 M(+52.1%) | -$17.32 M(+12.2%) |
Sep 2001 | - | -$4.01 M(+2.3%) | -$15.43 M(-12.9%) |
Jun 2001 | - | -$3.92 M(+19.2%) | -$17.71 M(+1.0%) |
Mar 2001 | - | -$3.29 M(-22.0%) | -$17.54 M(+22.1%) |
Dec 2000 | -$20.30 M(+335.8%) | -$4.22 M(-32.9%) | -$14.37 M(+41.5%) |
Sep 2000 | - | -$6.29 M(+67.8%) | -$10.15 M(+162.7%) |
Jun 2000 | - | -$3.75 M(+3066.9%) | -$3.86 M(+3166.9%) |
Mar 2000 | - | -$118.30 K | -$118.30 K |
Dec 1999 | -$4.66 M | - | - |
FAQ
- What is Cassava Sciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cassava Sciences?
- What is Cassava Sciences annual EBIT year-on-year change?
- What is Cassava Sciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cassava Sciences?
- What is Cassava Sciences quarterly EBIT year-on-year change?
- What is Cassava Sciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cassava Sciences?
- What is Cassava Sciences TTM EBIT year-on-year change?
What is Cassava Sciences annual earnings before interest & taxes?
The current annual EBIT of SAVA is -$105.96 M
What is the all time high annual EBIT for Cassava Sciences?
Cassava Sciences all-time high annual earnings before interest & taxes is $31.36 M
What is Cassava Sciences annual EBIT year-on-year change?
Over the past year, SAVA annual earnings before interest & taxes has changed by -$25.94 M (-32.41%)
What is Cassava Sciences quarterly earnings before interest & taxes?
The current quarterly EBIT of SAVA is -$30.62 M
What is the all time high quarterly EBIT for Cassava Sciences?
Cassava Sciences all-time high quarterly earnings before interest & taxes is $32.90 M
What is Cassava Sciences quarterly EBIT year-on-year change?
Over the past year, SAVA quarterly earnings before interest & taxes has changed by -$2.74 M (-9.84%)
What is Cassava Sciences TTM earnings before interest & taxes?
The current TTM EBIT of SAVA is -$134.75 M
What is the all time high TTM EBIT for Cassava Sciences?
Cassava Sciences all-time high TTM earnings before interest & taxes is $31.36 M
What is Cassava Sciences TTM EBIT year-on-year change?
Over the past year, SAVA TTM earnings before interest & taxes has changed by -$30.64 M (-29.43%)